Product
Truvada + Estradiol
1 clinical trial
3 indications
Indication
HIVIndication
ProphylaxisIndication
Gender dysphoriaClinical trial
A Phase I Trial for the Evaluation of the Two-way Pharmacokinetic-pharmacodynamic (PD) Interaction of Gender Affirming Exogenous Estrogen (With Testosterone Suppression) on TDF/FTC PrEP in Transgender Women (TGW)Status: Recruiting, Estimated PCD: 2025-03-01